GB2487616A - Plant-based drug for diabetes - Google Patents
Plant-based drug for diabetes Download PDFInfo
- Publication number
- GB2487616A GB2487616A GB1116852.3A GB201116852A GB2487616A GB 2487616 A GB2487616 A GB 2487616A GB 201116852 A GB201116852 A GB 201116852A GB 2487616 A GB2487616 A GB 2487616A
- Authority
- GB
- United Kingdom
- Prior art keywords
- copies
- diabetes
- parts
- papaya
- poria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 32
- 239000003814 drug Substances 0.000 title claims abstract description 26
- 229940079593 drug Drugs 0.000 title claims abstract description 24
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 16
- 235000009467 Carica papaya Nutrition 0.000 claims abstract description 15
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 claims abstract description 14
- 244000017020 Ipomoea batatas Species 0.000 claims abstract description 13
- 235000002678 Ipomoea batatas Nutrition 0.000 claims abstract description 13
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 13
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 12
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 12
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 12
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 12
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 12
- 229940010454 licorice Drugs 0.000 claims abstract description 12
- 235000017276 Salvia Nutrition 0.000 claims abstract description 8
- 241000219780 Pueraria Species 0.000 claims abstract description 7
- 244000302512 Momordica charantia Species 0.000 claims abstract description 6
- 240000006432 Carica papaya Species 0.000 claims abstract description 5
- 240000007164 Salvia officinalis Species 0.000 claims abstract 2
- 239000000284 extract Substances 0.000 claims description 24
- 235000008216 herbs Nutrition 0.000 claims description 11
- 241000202807 Glycyrrhiza Species 0.000 claims description 9
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 claims description 6
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 claims description 6
- 241000222336 Ganoderma Species 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 241000719837 Anoectochilus Species 0.000 claims description 3
- 235000002723 Dioscorea alata Nutrition 0.000 claims description 3
- 235000007056 Dioscorea composita Nutrition 0.000 claims description 3
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 claims description 3
- 235000005362 Dioscorea floribunda Nutrition 0.000 claims description 3
- 235000004868 Dioscorea macrostachya Nutrition 0.000 claims description 3
- 235000005361 Dioscorea nummularia Nutrition 0.000 claims description 3
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 claims description 3
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 claims description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 21
- 235000000346 sugar Nutrition 0.000 description 13
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 241000219173 Carica Species 0.000 description 10
- 244000078912 Trichosanthes cucumerina Species 0.000 description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 241001072909 Salvia Species 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000001784 detoxification Methods 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 235000010575 Pueraria lobata Nutrition 0.000 description 2
- 244000046146 Pueraria lobata Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000001919 adrenal effect Effects 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 238000002266 amputation Methods 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- MPDGHEJMBKOTSU-WFJWTYAKSA-N (2s,4as,6as,6br,10s,12as)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid Chemical compound C12C(=O)C=C3C4C[C@@](C)(C(O)=O)CC[C@]4(C)CC[C@@]3(C)[C@]1(C)CCC1[C@]2(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-WFJWTYAKSA-N 0.000 description 1
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 1
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 240000004270 Colocasia esculenta var. antiquorum Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000008960 Diabetic foot Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 208000013600 Diabetic vascular disease Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 206010023379 Ketoacidosis Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027627 Miliaria Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000016222 Pancreatic disease Diseases 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010041277 Sodium retention Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229940039750 aconitine Drugs 0.000 description 1
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 201000009101 diabetic angiopathy Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- -1 flavin ring amide Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 208000018914 glucose metabolism disease Diseases 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000010112 ling-gui-zhu-gan decoction Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 201000004169 miliaria rubra Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000003170 nutritional factors Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229940108461 rennet Drugs 0.000 description 1
- 108010058314 rennet Proteins 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 235000021309 simple sugar Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 208000023516 stroke disease Diseases 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A drug for diabetes, containing: 2-6 parts sweet potato leaf; 1-6 parts yam; 1-3 parts licorice; 1-6 parts pueraria; 2-4 parts rehmanniae; 3-6 parts poria; 2-6 parts papaya; 1-4 parts bitter gourd/bitter melon; 1-3 parts yeast; 1-5 parts salvia.
Description
A diabetes drug The invention relates to drugs, specifically a treatment for diabetes drugs.
In the existing technology, diabetes has been difficult to cure a disease, although there are many drugs used to treat diabetes, but are not very effective treatment.
From the Western point of view, diabetes is a result of absolute or relative insulin secretion caused by increased blood glucose metabolism disorders caused by systemic endocrine metabolic disease. From the Chinese perspective, Diabetes Diabetes is a disease, divided on the consumer, the consumer, the next elimination, is the five internal organs are true, yin and yang imbalance, organs, pancreatic disorders, a variety of trace element imbalance causes a chronic disease.
Diabetes, elevated blood sugar is not that scary, but the complications of the hazards. Conventional medicine can only play a hypoglycemic effect of sugar control, because of its role in a single, can not control the complications. Brutal figures show: the current 40 million diabetics in China, 80% of patients associated with complications, including half of the patients eventually died of complications of diabetes. Diabetic retinopathy is the leading cause of blindness; 1 / 3 of those with acute myocardial infarction and 1 / 4 stroke and diabetic vascular disease has a direct relationship; vast majority of lower limb necrosis of lower limb amputees with vascular disease related to diabetes. As profit-driven, drug advertising publicity most hypoglycemic effect of drugs, while ignoring the complications of harm to patients with diabetes blood glucose control into a simple sugar treatment errors, not only so that patients lose their health, but also to families back a heavy economic burden for a diabetic patient per year cost of the sugar glucose is necessary to stabilize 5,000 yuan. However, after years of taking hypoglycemic agents, diet, and blood glucose after a fight in patients with diabetes found that his body is getting worse, increasingly blurred vision, body pain, limb numbness, decreased immunity, colds easily, wound healing, fatty liver, gallstones, gastrointestinal disorders, sexual dysfunction and so on. Serious complication of diabetic foot, only amputation; eye diseases so that patients lose the light; ketoacidosis, myocardial infarction, patients with uremia and even take lives. How to avoid amputation, blindness and death such a tragedy happen? Simply out ol control diabetes sugar to treatment errors, while the sugar in the blood glucose control, effective prevention and control of complications.
The purpose of the present invention for the pathogenesis of diabetes and clinical features of TOM Basic Theory, provides a low cost effective in the treatment of diabetes drugs.
Provide a diabetes drug, is the use of the following medicines or their extracts were prepared by mixing crushed; each herbs calculated by the number of copies, according to which: sweet potato leaf extract 2-6 copies, yam 1-6 copies Licorice 1-3 copies, Pueraria 1-6 copies, Rehmanniae 2-4 copies, Poria 3-6 copies, papaya 2-6 copies, bitter gourd were 1-4, 1-3 copies of the yeast, Salvia 1-5 copies; again Add the following extracts of herbs, medicinal herbs with the foregoing extract by adding weight ratio: Anoectochilus extract 2-7%, 2-9% glossy ganoderma powder.
In the treatment of diabetes drugs, including: sweet potato leaf extract 4 copies 3 copies of yam, licorice 2 copies 3 copies of puerarin, Rehmanniae 3 copies, Poria 5 copies 4 copies of papaya, bitter gourd 2 copies, 2 copies of the yeast, Salvia 3 copies.
In the treatment of diabetes drugs, including: sweet potato leaf extract 3 copies 2 copies of yam, licorice 1, Pueraria 1, Rehmanniae 2 copies, Poria 3 copies 2 copies of papaya, bitter gourd 1, yeast 1, Salvia 2 copies.
in the above drugs: Sweet potato leaf extracts: the major insulin f3 can repair damaged cells, promote the insulin 13 cells to restore damaged and proliferation of pancreatic islet cells to recuperate and vigor; directly address the shortage of people with diabetes and the relative lack of insulin is absolutely fundamental issue. In addition, from the natural extract of sweet potato leaves in the body can be transformed into a large number of arachidonic acid, which can reduce the role of blood lipids. Configuration of zinc, magnesium can promote the dissolution of the body-dimensional protein inhibition of thrombin generation, the blood vessels to dilate, to the role of anti-thrombosis; This product can effectively overcome the insulin resistance, in which the plant-specific peptide and protein molecular state, the body more easily than the animal insulin absorption, the long-term use can prevent diabetes complications.
Yam: the longevity of the product is good, taste flat, sweet, non-toxic. Lung, spleen, kidney, stomach. There spleen, thick stomach, lungs, kidney effect. Indications spleen diarrhea, Jiu Li, consumptive cough, nocturnal emission vaginal discharge, frequent urination, thirst, uterine prolapse.
Licorice: with Spleen Qi, detoxification, expectorant cough, urgency and pain relief, to reconcile the efficacy of various drugs. For the weak stomach, fatigue fatigue, palpitations shortness of breath, cough, sputum, abdominal, limb twin acute pain, carbuncle swollen sore, ease of drug toxicity, make five workers and injured seven, all wasting, through Jiuqiao, Lee Lotus, Yijing Yang Qi, strong bones, hot and cold solutions.
Glycyrrhetinic acid-like effect of corticosterone with the DNA, can promote sodium and water retention, increased potassium row, indicating mineralocorticoid-like effect; licorice extract, glycyrrhizin can atrophy of thymus, adrenal weight gain, blood eosinophfl leukocyte and lymphocytes decreased, increased urinary free type 17 -hydroxy corticosterone.
Kudzu: Sun Jie Ji, Touzhen diarrhea, Chufan thirst. Governance typhoid fever, headache, hot items strong, Fanre diabetes, diarrhea, dysentery, measles can not figure Ban, hypertension, angina, deafness.
Ethanol Fueraria extract, daidzein and puerarin significantly against aconitine-induced arrhythmias and the role of barium chloride, chloroform, puerarin also significantly reduced, adrenaline-induced arrhythmias time, puerarin could significantly reduced myocardial infarct size, is considered to be a 1-adrenergic receptor blockers.
Rehmanniae: sweet, bitter, cold. Can YangYinShengJin, heat and cooling blood.
Can promote blood clotting, increase peripheral leukocyte; to cardiac, diuretic, or high blood pressure; to protect the liver, lowering blood glucose; have enhanced immune function, anti-radiation damage and adrenal cortical hormone-like effect. Wound fluid for heat, thirst, dry throat, or dry stool; Diabetes, dry mouth and drink; blood heat Wang Xing, vomiting blood, Nvxue, hematochezia, uterine bleeding; warm disease, dry mouth, tongue crimson.
Poria: of sweet light levels, into the heart, lung, spleen. Diuresis with Shenshi, spleen and stomach, Ning Anshen effect. Can cure dysuria, edema, puffiness, phlegm, Keni, vomiting inverse, Vomiting, diarrhea, nocturnal emission, splashing muddy, palpitation, forgetfulness embolism. Poria and benefit from the water is transported through the health Pifei function to achieve, and other direct benefits of water of different traditional Chinese medicine. Lingguizhugan soup, Sijunzitang, four Ling Poria soup and so is compatible with the common prescriptions.
Diuretic, the Fuling Medicinal 70% alcohol cold soak, be soaked with liquid when the alcohol evaporates, add distilled water diluted urine significantly increased after treatment.
Salvia: Bitter, slightly cold. The heart, liver. With blood to regulate menstruation, blood stasis and pain, carbuncle cooling consumption, pure heart Chufan, nourishing and sedative effect. Indications, irregular menstruation, dysmenorrhea, amenorrhea, Zheng Jia accumulation, abdominal irritation, pain, heat paralysis, sore throat, upset, sleepless; hepatosplenomegaly, angina pectoris.
Papaya ingredients: papaya base, papain, rennet papaya, tomatoes, hydrocarbons, vitamins B, C, E, sugar, protein, fat, carotene, hidden flavin, flavin butterfly Mei, hidden flavin ring amide and so on. Natured, slightly cold, sweet. It has a unique anti-tumor effect of papaya base of lymphatic leukemia cells with strong anti-cancer activity.
Bitter: bitter gourd bitter odor, non-toxic, cold, into the heart, liver, spleen, lung; bitter summer heat with the heat, nourishing Qi, kidney and spleen, nourish liver eyesight of the efficacy of the treatment of dysentery, sores, heat stroke, fever, prickly heat too much, conjunctivitis and other diseases have a certain effect. High vitamin C content of bitter gourd, with the prevention of scurvy, protect cell membranes, prevent atherosclerosis, improve stress ability to protect the heart and so on. The active ingredients in bitter gourd can inhibit carcinogenesis and the promotion of normal cell recovery of mutant cells with certain anti-cancer effect. Bitter gourd in the prime as the "killer fat" can reduce the intake of fats and polysaccharides. Heat cured Firelight, detoxification, eyesight, qi, refined, refreshing thirst quencher, treatment carbuncle.
important nutritional factor of yeast species: Valley off glutathione: an extremely valuable activity of small peptides, a "super antioxidant," said, can efficiently remove harmful free radicals, protecting cells, play a anti-aging, protect the liver, a variety of detoxification, prevention of exercise-induced anemia effect.
Product contains chromium yeast: natural organic chromium supplement.
Composed of glucose measurement factor (CTP), strengthening the role of insulin to help stabilize blood sugar, and prevent arteriosclerosis.
Formosanus: Sweet, cold, with heat and cooling blood, sugar, desiccant detoxification, balance of yin and yang, strengthening and restoring the yin and yang complement each other, fluid beauty, qi and blood, internal organs, life support functions of sickness. Into the kidney, heart, lung three classics, to comprehensively improve the human immune system, enhance the body resistance to disease.
Indications Hyperactivity cough, tuberculosis, hemoptysis, hematuria, children convulsion, tetanus, nephritis, edema, Fengshibitong, bruises, snake bites, bronchitis, cystitis, diabetes, hematuria, acute and chronic hepatitis, rheumatic arthritis, cancer and other difficult cases.
Glossy ganoderma powder: the pancreas can improve blood circulation, improve physiological function of the pancreas, lowers blood sugar and other effects. On spontaneous, night sweats, Shenpi fatigue, shortness of breath, palpitations, insomnia, dizziness, chest tightness, gas hold back, poor appetite, backache and other symptoms were significantly improved Tuiruan, significant effect on lowering blood lipids.
In the drug formulation, the sweet potato leaf extract, yam, licorice, kudzu root, Rehmanniae, Poria, Salvia, papaya, bitter gourd and other raw materials is a drug with the food source, and compatibility of the herbs, solve diabetes during treatment with Other drugs need to stabilize blood glucose sugar problems, and better treatment.
Implementation Example: The following Chinese herbal medicines used to extract and mixed by crushing, or prepared from, can be made into tablets or capsules; each herbs calculated by the number of copies, according to which: sweet potato leaf extracts were 2-6, 1-6 yam copies 1-3 copies of licorice, Pueraria 1-6 copies, Rehmanniae 2-4 copies, Poria 3-6 copies, papaya 2-6 copies, bitter gourd were 1-4, 1-3 copies of the yeast, Salvia 1-5 copies; then add the following extracts of herbs, medicinal herbs with the foregoing extract by adding weight ratio: Anoectochilus extract 2-7%, 2-9% glossy ganoderma powder.
In the treatment of diabetes drugs: sweet potato leaf extract 4 copies 3 copies of yam, licorice 2 copies 3 copies of puerarin, Rehmanniae 3 copies, Poria 5 copies 4 copies of papaya, bitter gourd 2 copies, 2 copies of the yeast, SM 3 copies.
In the treatment of diabetes drugs: sweet potato leaf extract 3 copies 2 copies of yam, licorice 1, Pueraria 1, Rehmanniae 2 copies, Poria 3 copies 2 copies of papaya, bitter gourd 1, yeast 1, SM 2 copies.
Directions: three times a day 5, before meals, through 56 clinical cases observed 96% of the total effective rate after taking the drug significantly improved symptoms.
The drug effect: through the "up", added directly to insulin, "down", to quickly lower the blood sugar levels; "control" effective control of postprandial hyperglycemia; "repair" to repair an additional p-cell; "pass" to clear the glucose metabolic pathways; "defense", prevention and control of diabetes complications.
Help stabilize blood sugar and prevent complications, 54 cases of clinical cases by reaction, after three months after the trial of the drug, blood sugar levels stable, reducing the use of hypoglycemic drugs, no new complications of diabetes; physical improvement, significant improvement in physical, the ability to increase resistance to disease; to improve the quality of sleep.
Claims (3)
- CLAIMS1. A diabetes drug, characterized in that, it was prepared by crushing and mixing the following herbs or their extracts, and each herbs calculated by the number of copies, according to which: sweet potato leaf extracts were 2-6, yams 1 -6 copies, licorice 1- 3 copies, Pueraria 1-6 copies, Rehmanniae 2-4 copies, Poria 3-6 copies 2-6 copies papaya, bitter gourd were 1-4, 1-3 copies of the yeast, SM 1 -5 copies; then add the following extracts of herbs, medicinal herbs with the foregoing extract by adding weight ratio: Anoectochilus extract 2-7%, 2-9% glossy ganoderma powder.
- 2. The diabetes drug as in claim 1, characterized in that, including: sweet potato leaf extract 4 copies 3 copies of yam, licorice 2 copies 3 copies of puerarin, Rehmanniae 3 copies, Poria 5 copies, 4 copies of papaya, 2 copies of bitter melon, yeast 2 copies 3 copies of Salvia.
- 3. The diabetes drug as in claim 1, characterized in that, including: sweet potato leaf extract 3 copies, 2 copies of yam, licorice 1, Pueraria 1, Rehmanniae 2 copies, Poria 3 copies 2 copies of papaya, bitter gourd 1, yeast 1, SM 2 copies.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1116852.3A GB2487616A (en) | 2011-01-25 | 2011-09-30 | Plant-based drug for diabetes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110026266XA CN102100828A (en) | 2011-01-25 | 2011-01-25 | Medicament for treating diabetes mellitus |
GB1116852.3A GB2487616A (en) | 2011-01-25 | 2011-09-30 | Plant-based drug for diabetes |
Publications (2)
Publication Number | Publication Date |
---|---|
GB201116852D0 GB201116852D0 (en) | 2011-11-09 |
GB2487616A true GB2487616A (en) | 2012-08-01 |
Family
ID=44994230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1116852.3A Withdrawn GB2487616A (en) | 2011-01-25 | 2011-09-30 | Plant-based drug for diabetes |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2487616A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020011015A (en) * | 2000-07-31 | 2002-02-07 | 김철주 | Compositions for the treatment of diabetes |
CN101530538A (en) * | 2008-03-13 | 2009-09-16 | 北京天科仁祥医药科技有限公司 | Oral preparation for treating diabetes mellitus |
CN101607031A (en) * | 2009-07-31 | 2009-12-23 | 董哲 | Medicated wine of a kind of treatment and prevent diabetes and preparation method thereof and using method |
CN101607073A (en) * | 2008-06-20 | 2009-12-23 | 刘广伦 | A kind of traditional biological technology is cultivated the method for Chinese medicine health care product Herba Swertiae davidi and healthy liquid thereof |
CN101972415A (en) * | 2010-06-07 | 2011-02-16 | 中山市新运来医药科技开发有限公司 | Traditional Chinese medicine-decocted soup or granule preparation for recuperating and treating diabetes |
CN102100828A (en) * | 2011-01-25 | 2011-06-22 | 王启凌 | Medicament for treating diabetes mellitus |
-
2011
- 2011-09-30 GB GB1116852.3A patent/GB2487616A/en not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020011015A (en) * | 2000-07-31 | 2002-02-07 | 김철주 | Compositions for the treatment of diabetes |
CN101530538A (en) * | 2008-03-13 | 2009-09-16 | 北京天科仁祥医药科技有限公司 | Oral preparation for treating diabetes mellitus |
CN101607073A (en) * | 2008-06-20 | 2009-12-23 | 刘广伦 | A kind of traditional biological technology is cultivated the method for Chinese medicine health care product Herba Swertiae davidi and healthy liquid thereof |
CN101607031A (en) * | 2009-07-31 | 2009-12-23 | 董哲 | Medicated wine of a kind of treatment and prevent diabetes and preparation method thereof and using method |
CN101972415A (en) * | 2010-06-07 | 2011-02-16 | 中山市新运来医药科技开发有限公司 | Traditional Chinese medicine-decocted soup or granule preparation for recuperating and treating diabetes |
CN102100828A (en) * | 2011-01-25 | 2011-06-22 | 王启凌 | Medicament for treating diabetes mellitus |
Also Published As
Publication number | Publication date |
---|---|
GB201116852D0 (en) | 2011-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100374140C (en) | Health-care for diabetes | |
CN102669366B (en) | Liver-protecting lung-moistening tea and preparation method thereof | |
CN103083535A (en) | Dark tea composition and application in weight losing field | |
CN101284122A (en) | Soft capsules for resisting the climate sickness | |
CN103445116B (en) | Healthcare radix puerariae nutrition powder with blood fat regulating effect | |
WO2008014256A2 (en) | Composition including superoxide dismutase and prickly-pear cactus for minimizing and preventing hangovers | |
CN101884783B (en) | Wheat bran polypeptide-containing anti-fatigue traditional Chinese medicine and preparation method thereof | |
CN101491338A (en) | Nutrient food capable of improving sleep and preparation method thereof | |
CN102119939B (en) | Angiosperm bee pollen water extract for treating fatty liver and preparation method and application thereof | |
AU2021103674A4 (en) | Preparation method of healthcare wine for dispelling cold and tonifying kidney | |
CN102631466A (en) | Health care product for regulating blood lipid and preparation method thereof | |
CN102145025B (en) | Pine pollen extract for treating fatty liver as well as preparation method and application thereof | |
CN101554396B (en) | Traditional Chinese medicine for treating diabetes and hyperlipidemia | |
CN101745042B (en) | Composition with effects of relieving alcoholism and protecting liver and preparation method thereof | |
CN103977390A (en) | Method for preparing ginger-onion medicinal liquor composition and application thereof | |
GB2487616A (en) | Plant-based drug for diabetes | |
CN103495115B (en) | A kind of to the medicative medicated wine of diabetes tool | |
CN105194023A (en) | High-grade buccal tablet capable of assisting in giving up smoking | |
CN104524003A (en) | Traditional Chinese medicine composition with golden camellia and radix pueraiae | |
CN104173745A (en) | Nourishing and body-building Mongolian medicine | |
CN103461867B (en) | Chickpea healthcare nutrition powder with function of regulating blood lipid | |
CN108929834A (en) | Dendrobium candidum functionality Maotai-flavor liquor and preparation method thereof | |
CN110755523B (en) | Composition for improving hyperglycemia and preparation method thereof | |
CN107375693A (en) | A kind of traditional Chinese medicine health care product for strengthening immunity of organisms and preparation method thereof | |
CN108013170A (en) | Double golden tea of benevolence profit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |